173 related articles for article (PubMed ID: 2312446)
1. Susceptibility to fusidic acid among Danish Staphylococcus aureus strains and fusidic acid consumption.
Faber M; Rosdahl VT
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():7-14. PubMed ID: 2312446
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
Edslev SM; Clausen ML; Agner T; Stegger M; Andersen PS
J Antimicrob Chemother; 2018 Apr; 73(4):856-861. PubMed ID: 29253168
[TBL] [Abstract][Full Text] [Related]
3. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
[TBL] [Abstract][Full Text] [Related]
4. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Afset JE; Maeland JA
Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
[TBL] [Abstract][Full Text] [Related]
6. A novel fusidic acid resistance determinant, fusF, in Staphylococcus cohnii.
Chen HJ; Hung WC; Lin YT; Tsai JC; Chiu HC; Hsueh PR; Teng LJ
J Antimicrob Chemother; 2015 Feb; 70(2):416-9. PubMed ID: 25313205
[TBL] [Abstract][Full Text] [Related]
7. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
O'Neill AJ; Cove JH; Chopra I
J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
[TBL] [Abstract][Full Text] [Related]
8. Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate.
Price CTD; Gustafson JE
J Med Microbiol; 2001 Jan; 50(1):104-106. PubMed ID: 11192496
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus resistance to antibiotics and spread of phage types.
Kareiviene V; Pavilonis A; Sinkute G; Liegiūte S; Gailiene G
Medicina (Kaunas); 2006; 42(4):332-9. PubMed ID: 16687905
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
Rennie RP
J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
[TBL] [Abstract][Full Text] [Related]
11. Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus.
Price CT; O'Brien FG; Shelton BP; Warmington JR; Grubb WB; Gustafson JE
J Antimicrob Chemother; 1999 Jul; 44(1):57-64. PubMed ID: 10459810
[TBL] [Abstract][Full Text] [Related]
12. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous expression of fusidic acid resistance in Staphylococcus aureus with plasmid or chromosomally encoded fusidic acid resistance genes.
O'Brien FG; Botterill CI; Endersby TG; Lim RL; Grubb WB; Gustafson JE
Pathology; 1998 Aug; 30(3):299-303. PubMed ID: 9770197
[TBL] [Abstract][Full Text] [Related]
15. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
Woodford N; Afzal-Shah M; Warner M; Livermore DM
J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
[TBL] [Abstract][Full Text] [Related]
18. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
O'Neill AJ; Larsen AR; Henriksen AS; Chopra I
Antimicrob Agents Chemother; 2004 Sep; 48(9):3594-7. PubMed ID: 15328136
[TBL] [Abstract][Full Text] [Related]
19. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
Memikoğlu KO; Bayar B; Kurt O; Cokça F
Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of fusidic acid resistance in Staphylococcus aureus.
Besier S; Ludwig A; Brade V; Wichelhaus TA
Mol Microbiol; 2003 Jan; 47(2):463-9. PubMed ID: 12519196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
